Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalassemia.

Alan R Cohen, Renzo Galanello, Dudley J Pennell

    Hematology. American Society of Hematology. Education Program
    |November 25, 2004
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Variable Treatment Effects of Cranial Surgery in Pediatric Severe Traumatic Brain Injury.

    Neurosurgery·2026
    Same author

    Emergency Medical Services Time on Scene Associated with Reduced Dead-on-Arrival Status Among Pediatric Patients with Severe Traumatic Brain Injury.

    Prehospital emergency care·2025
    Same author

    Pott's puffy tumor in the post-COVID era.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2025
    Same author

    Neuro-ophthalmic clues affecting the surgical approach to a brain tumor: the case of a craniopharyngioma masquerader.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2025
    Same author

    Machine Learning Insights Into Social Determinants Driving Child Abuse in Pediatric Traumatic Brain Injury.

    Neurosurgery·2025
    Same author

    Variation of demographic and socioeconomic factors associated with pediatric traumatic brain injury: a geospatial analysis.

    Journal of neurosurgery. Pediatrics·2025
    Same journal

    Nze C, Flowers CR. Barriers to accessing cellular therapy for patients receiving care in community practices. Hematology Am Soc Hematol Educ Program. 2023;2023(1):382-385.

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma.

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    Emerging immunotherapy advances for non-Hodgkin lymphomas: engaging T cells in the fight.

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    Anticoagulants in hematologic malignancies: what is the data?

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    Diagnosis and management of cold agglutinin disease.

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    What to know about rare B-cell malignancies in 2025.

    Hematology. American Society of Hematology. Education Program·2025
    See all related articles

    Advances in thalassemia care include new iron chelation therapies and improved monitoring for cardiac iron overload. Emerging adult complications like hepatitis C and thrombosis require new management strategies, alongside evolving epidemiological trends in North America.

    Area of Science:

    • Hematology
    • Genetics
    • Internal Medicine

    Background:

    • Thalassemia management is evolving due to demographic shifts and improved patient survival.
    • Increased recognition of thalassemia disorders in North America necessitates updated clinical approaches.
    • Managing iron overload and its complications remains a critical challenge in transfusion-dependent disorders.

    Purpose of the Study:

    • To describe recent advancements in thalassemia treatment and care.
    • To highlight new strategies for iron chelation therapy and monitoring.
    • To address emerging complications and epidemiological changes in thalassemia.

    Main Methods:

    • Review of new iron chelating agents, including orally active and parenterally administered options.
    • Application of magnetic resonance imaging (MRI) techniques for assessing cardiac iron loading.

    Related Experiment Videos

  • Analysis of emerging adult complications such as hepatitis C, thrombosis, and pregnancy-related risks.
  • Discussion of changing epidemiology, including Hb E-beta thalassemia and alpha thalassemia variants.

    • Main Results:

    • Development of novel iron chelators (e.g., deferiprone, ICL670, HBED) offering improved efficacy and administration.
    • MRI-based T2* measurements show promise for guiding chelation therapy and assessing cardiac iron.
    • Hepatitis C and thrombosis are significant adult complications requiring aggressive management.
    • Epidemiological shifts in North America include increased prevalence of Hb E-beta and alpha thalassemia.

    Conclusions:

    • New chelation strategies and MRI monitoring are redefining thalassemia management.
    • Addressing adult complications and understanding evolving epidemiology are crucial for comprehensive care.
    • Future directions involve optimizing therapy for specific thalassemia types and patient populations.